News | Infectious diseases

News

Hospital to offer test that cuts wait for identifying secondary infection in COVID-19 patients

Results from a study on a DNA test showed it could provide accurate pathogen detection and antibiotic resistance prediction within eight hours.…

Published: 3 December 2021

News

Second monoclonal antibody treatment for COVID-19 approved in the UK

Sotrovimab has been approved for patients with mild-to-moderate COVID-19 who are at high risk of developing severe disease.…

Published: 2 December 2021

News

Molnupiravir less effective at preventing death from COVID-19 than previously thought, study update shows

Manufacturers maintain the latest trial results still support the efficacy of the drug for mild-to-moderate COVID-19 in adults at high risk for disease progression.…

Published: 26 November 2021

Feature

Everything you need to know about the COVID-19 therapy trials

There are thousands of clinical trials investigating treatments and preventative measures for COVID-19.…

Published: 26 November 2021

News

NICE backs first long-acting injectable treatment for HIV

The antiretroviral drugs cabotegravir with rilpivirine will be given as two separate intramuscular injections every two months.…

Published: 19 November 2021

News

Oral antiviral may cut risk of COVID-19 hospitalisation by nearly 90%, manufacturer claims

Results from an interim analysis suggest an investigational antiviral from Pfizer may reduce the risk of hospitalisation or death in COVID-19 patients.…

Published: 5 November 2021

News

‘Game-changing’ COVID-19 antiviral drug gets approval in UK for at-risk patients

Announcing the regulatory approval, Sajid Javid said the government is "working at pace" to deploy molnupiravir to patients in a national study "as soon as possible".…

Published: 4 November 2021

Feature

Antivirals for COVID-19: five questions that must be answered

The UK government has secured 730,000 doses of two new oral antivirals that it hopes will help to stop COVID-19 in its tracks and keep vulnerable people out of hospital this winter.…

Published: 21 October 2021

Feature

Never again: training our immune systems to neutralise killer coronaviruses

Experimental universal coronavirus vaccines target multiple related viruses, with the aim of warding off other pandemics before they can wreak the havoc endured while the world waited for a vaccine against SARS-CoV-2.…

Published: 7 October 2021

News

Oral antiviral may halve COVID-19 hospitalisation risk, claims manufacturer

Interim results from a trial using data from 775 patients with mild-to-moderate COVID-19 show that no deaths were reported in those given molnupiravir, compared with eight deaths in those who were given a placebo.…

Published: 1 October 2021